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Acupuncture for Migraine: 
A Systematic Review of 
Chinese Literature
A B S T R A C T
Introduction: Acupuncture is widely used for the treatment of migraine, but its effectiveness is 
inconclusive based on findings of two recent systematic reviews. However, these reviews included 
very few studies conducted in Asian countries. Research papers published in Chinese are yet to 
be reviewed to determine their role in the overall understanding of the effectiveness and safety 
of acupuncture for migraine. Objectives: Is acupuncture more effective than no treatment, 
sham/placebo acupuncture, or as effective as other interventions for migraine? Methods: Search 
Strategies: Electronic search was performed in the two most comprehensive Chinese e-databases, Vi 
Pu and Wan Fang. Keywords used were a combination of acupuncture, headache, migraine, Chinese 
medicine, electroacupuncture and point-stimulation. Selection Criteria: Randomised, controlled 
trials comparing acupuncture with any type of control interventions and reporting at least one of 
the clinically related outcome measures for migraine were selected. Data Collection and Analysis: 
Characteristics of the studies were extracted by two independent reviewers. Reporting quality and 
validity were assessed using the Jadad Scale, Internal Validity Scale and Oxford Pain Validity Scale. 
STRICTA was used to assess the reporting quality of acupuncture treatment. RevMan 4.2 was 
used for data analysis. Results: Seventeen studies with a total of 2097 participants (median 91; 
range 62–216) met the inclusion criteria. Ten studies compared acupuncture alone with western 
medications. The remaining seven trials compared a combined therapy of acupuncture and other 
therapies with western medications. None of the studies compared acupuncture with no-treatment 
control or sham/placebo acupuncture. None of the 17 studies was considered of high quality. 
Studies indicated that acupuncture alone was superior to western medications (RR 1.55, 95% CI 
1.27 to 1.88). In comparison to studies included in the other two reviews, the Chinese studies in 
this review had a larger sample size and acupuncture treatments were more frequent. Conclusion: 
There is moderate evidence that acupuncture is more effective than western pharmacotherapy. Due 
to the poor quality and validity of included studies, this conclusion requires further assessment. 
Data from Chinese literature should be included in future systematic reviews.
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Introduction 
Migraine is a common, disabling, and typically unilateral 
headache disorder with symptoms such as nausea, vomiting, 
phonophobia or photophobia. Approximately 16% of 
Australians suffer from migraine.1 Direct and indirect costs 
of migraine as a whole in Australia from 1989 to 1990 were 
estimated to be between 302 and 721 million dollars.2
Current treatments for migraine focus on symptomatic 
management using anti-inflammatory medications, opioids 
and ergots. These western medications have provided some 
relief, but not without risks, such as drug overuse with resultant 
headache exacerbation. More and more migraine sufferers 
seek complementary therapies, including acupuncture, for 
relief. A recent Italian study reported that the percentages of 
complementary and alternative medicine users in chronic and 
episodic migraine sufferers were 50% and 27%, respectively.3 
The role of acupuncture in migraine treatment, however, 
remains uncertain.4 Currently available systematic reviews 
(SRs) on this topic have focused on published studies from 
western countries, with few studies in Asian languages.4-6 
Thus, the majority of Asian studies were neglected, possibly 
due to language difficulties and a lack of access to the relevant 
databases.4 In China, acupuncture is widely used and data from 
this region need to be taken into consideration in determining 
the effectiveness and safety of acupuncture for migraine. 
Objectives
Through systematically reviewing Chinese literature, the 
objectives of this review were to determine whether acupuncture 
was:
1. more effective than no treatment; 
2. more effective than ‘sham/placebo’ acupuncture; and
3. as effective as other interventions for migraine.
Methods
CRITERIA fOR CONSIDERINg STUDIES 
fOR THIS REVIEW
TyPES Of STUDIES
Studies with a randomised and controlled design were included. 
Quasi-randomised studies (e.g. by the order of admission or 
date of birth) were also included. Ongoing or unpublished 
studies were excluded. 
TyPES Of PARTICIPANTS 
Participants were migraine patients diagnosed according to 
standard criteria, such as those recommended by the Ad Hoc 
Committee of the National Institute of Neurological Diseases 
and Blindness7 or the International Headache Society (IHS).8 
Studies that did not separate migraine patients from those with 
other types of headache, such as tension-type headache, were 
excluded. 
TyPES Of INTERVENTION 
Studies that involved needle insertion at acupuncture points, 
tender points, or trigger points, and other invasive methods 
of stimulating these points (e.g. electroacupuncture) were 
included. Studies examining non-invasive acupuncture, such as 
laser acupuncture or acupressure, were excluded, so were studies 
utilising point-injection alone. Studies comparing a combined 
therapy of acupuncture and Chinese herbal medicine or Tuina 
with a control group were included because acupuncture was 
often used together with other therapies in clinical practice. 
Control interventions considered were:
• no treatment,
• sham or placebo acupuncture, or
• other active treatments.
Studies comparing different modalities of acupuncture were 
excluded, for instance, those comparing manual acupuncture 
with electroacupuncture. Studies without a valid control group, 
meaning that the effect of acupuncture could not be assessed 
(for instance, comparing acupuncture with acupuncture plus 
Qigong), were also excluded. 
TyPES Of OUTCOME MEASURES
Included studies should report at least one clinically related 
outcome for migraine, such as frequency or intensity of 
migraine or number of respondents. Trials reporting only 
physiological or laboratory parameters as outcome measures, 
such as electroencephalogram, were excluded. 
We extracted data of the ‘global response’ to treatment. 
Response was defined as at least 50% improvement in our 
review. We estimated whether 50% improvement was met 
from the description provided by the authors. for instance, 
Lao9 recorded the reduction of migraine index (MI) during the 
third month after the end of the treatment. The MI reduction 
between 90% and 100% was considered as ‘cured’, between 
55% and 89% as ‘marked improvement’, between 20% and 
54% as ‘improvement’ and less than 20% as ‘no effect’. The 
participants in the first two groups were considered to be 
respondents in our review. Most studies did not report the 
immediate and the long-term effects separately. for instance 
Zhou10 defined ‘improvement’ as more than 50% reduction 
of MI in the three months after the end of the treatment. 
Consequently, the 50% improvement in our review refers to 
the global response to acupuncture at 0–12 months after the 
treatment, and is not specific to either the immediate effect or 
the long-term effect. Relative risks and their 95% confidence 
intervals were calculated. 
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SEARCH STRATEgy fOR IDENTIfICATION Of 
STUDIES
‘Acupuncture (针灸)’, ‘electroacupuncture (电针)’, ‘Chinese 
medicine (中医药疗法)’, ‘point-stimulation (穴位刺激)’, 
‘headache (头痛)’ and ‘migraine (偏头痛)’ were the keywords 
searched in the two largest Chinese electronic databases, Vi Pu 
(重庆维普, www.cqvip.com, inception 1989) and Wan Fang 
(万方数据, www.wanfangdata.com.cn, inception 1982) for 
papers published from the inception of the databases to August 
2006. 
METHODS 
ELIgIBILITy 
Of 266 papers found, 177 were either not RCTs, used Chinese 
herbs as the active intervention, or did not have a valid control 
intervention. A further 55 papers were excluded because they 
reported other types of headache. Two authors (yyW and ZZ) 
assessed the remaining 34 papers. Two were excluded because 
non-invasive acupuncture was used and seven were excluded 
due to the use of point-injection alone as the treatment. A 
further eight were eliminated for not providing any clinically 
relevant outcome measures. finally, a total of 17 studies were 
included and analysed. The following flowchart illustrates the 
process of identifying studies (figure 1). 
DATA ExTRACTION
Information on participants, randomisation, blinding 
interventions, outcome measures and results were extracted 
using the standard form adopted by Melchart and colleagues.4 
One reviewer (yyW) extracted the data. Another reviewer 
(ZZ) checked the extraction according to the pre-defined 
form. Differences between the reviewers were resolved through 
discussion. 
ASSESSMENT Of QUALITy
The quality of included studies was assessed independently 
by two reviewers using the Jadad Scale,11 the Internal Validity 
Scale (IVS),12 and the Oxford Pain Validity Scale (OPVS).13 
The former two scales have been used in several SRs on 
acupuncture.4,14 Studies scoring three or more points on the 
Jadad scale are considered of high quality, which is 60% of the 
maximum score. OPVS was designed specifically to examine 
the internal validity of trials in the field of pain research.13 
Points awarded for each item of the Jadad Scale, IVS and 
OPVS are listed in order for each trial in Table 1. In addition, 
the Standards for Reporting Interventions in Controlled Trials 
of Acupuncture (STRICTA) were used to assess the reporting 
quality of acupuncture interventions.15  
Concealment of allocation is the process of concealing 
assignments of the interventions. We adopted the method 
recommended by the Cochrane Collaboration to assess whether 
allocation concealment was adequate, uncertain, inadequate or 
not mentioned, and scored A, B, C and D, appropriately.16 
This method has been used by other systematic reviews.4,17-19 
‘A’ refers to studies adopting correct concealment methods, 
such as using centralised randomisation or sequentially 
numbered, sealed, opaque envelopes. If studies do not report 
any concealment approach, ‘B’ should be coded. Category C 
includes the use of case record numbers, dates of birth or days 
of the week, and any procedure that is entirely transparent 
before allocation, such as an open list of random numbers. ‘D’ 
refers to studies that clearly state that allocation concealment 
was not used. 
DATA ANALySIS 
RevMan 4.2 was used for meta-analysis. If significant 
heterogeneity among the trials was detected with the I2 statistic 
(I2 ≥ 50%), a random-effects model was used. Otherwise, a 
fix-effects model was used. for continuous data, weight or 
standard mean difference was used; for dichotomy data, relative 
risk was used.
We adopted the method described by van Tulder and colleagues 
in 2003 for the qualitative assessment of the overall evidence. 
This method classifies the evidence into strong, moderate, 
limited, conflicting or no evidence, depending on the quality, 
number and results of the studies.20
266 studies
89 studies
34 studies
32 studies
25 studies
17 studies
177 excluded for not being RCTs, 
using Chinese herbs as the 
study intervention, or not having 
a valid control intervention
55 excluded for reporting other 
types of headache
2 excluded for using non-
invasive acupuncture treatment
7 excluded for using point-
injection alone as the studied 
intervention 
8 excluded for not providing 
clinically relevant outcome 
measures
fIgURE 1  A flowchart illustrating the process 
of study identification
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TABLE 1   Characteristics of included studies
Author and date Intervention Sample population* Outcomes# Follow-up Drop-out
Zhou JH 
(2005) 
Acupuncture vs western 
medication
Acu: n = 35
WM: n = 35
▲ 6 months No
Wang B 
(2004) 
Acupuncture vs western 
medication
Acu: n = 125
WM: n = 61
▲ N/A No
Cui R, et al. 
(2004) 
Acupuncture vs western 
medication
Acu: n = 48
WM: n = 38
▲ 3 months No
Feng SL, et al. 
(2003) 
Acupuncture vs western 
medication
Acu: n = 35
WM: n = 27
▲ 2 months No
Zhang YC, et al. 
(2002) 
Acupuncture vs western 
medication
Acu: n = 106
WM: n = 110
■ 1 year No
Liu KY, et al. 
(2001) 
Acupuncture vs western 
medication
Acu: n = 43
WM: n = 43
▲ and 
frequency and 
duration
1 month No
Li W, et al. 
(1998) 
Acupuncture vs western 
medication
Acu: n = 70 
WM: n = 32
▲ N/A yes
Chen XS 
(1997) 
Acupuncture vs western 
medication
Acu: n = 45
WM: n = 30
■ 6 months No
Zhou LS 
(2003) 
Acupuncture vs western 
medication
Acu: n = 43
WM: n = 20
▲ 3 months No
Lao JX 
(2003) 
Electronic acupuncture vs 
western medication
Acu: n = 87
WM: n = 61
▲ 2 months No
Wang JL, et al. 
(2004)
Acupuncture plus Chinese 
medicine injection vs 
western medication
Acu: n = 60
WM: n = 60
■ 6 months No
Liu Y, et al. 
(2002)
Acupuncture plus acupoint 
injection vs western 
medication
Acu: n = 54
WM: n = 52
■ 8 weeks No
Lu ZQ 
(2004)
Acupuncture plus massage 
vs western medication
Acu: n = 54
WM: n = 30
■ 6 months yes (16)
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Number and percentage of 
respondents: Treatment vs Control
Quality
Allocation 
concealment†
Treatment: 21/35, 60%
Control: 9/35, 25.7%
Jadad: 1-0-0-0-1
IVS: 0.5-0-0.5-0-0-1
OPVS: 0-3-2-0-1-1-0-1
C
Treatment: 100/125, 80%
Control: 36/61, 59%
Jadad: 1-0-0-0-1
IVS: 0.5-0-1-0-0-1
OPVS: 0-3-2-0-1-1-0-1
B
Treatment: 28/48, 58.3%
Control: 17/38, 44.7%
Jadad: 1-0-0-0-1
IVS: 0.5-0-1-0-0-1
OPVS: 0-3-2-0-1-0-0-1
C
Treatment: 23/35, 65.7%
Control: 7/27, 25.9%
Jadad: 1-0-0-0-1 
IVS: 0.5-0-0.5-0-0-1
OPVS: 0-3-2-0-1-0-0-1
B
Treatment: 63/106, 59.4%
Control: 24/110, 21.8%
Jadad: 1-0-0-0-1 
IVS: 0.5-0-0-0-0-1
OPVS: 0-3-2-0-1-1-0-1
B
Treatment: 33/43, 76.7%
Control: 25/43, 58.1%
frequency: 0.3 ± 1.4 vs 2.6 ± 1.6
Duration: 2.54 ± 1.37 vs 14.7 ± 15.6
Jadad: 1-0-0-0-1 
IVS: 0.5-0-1-0-0-1
OPVS: 0-3-2-0-1-1-1-1
B
Treatment: 37/70, 52.9%
Control: 15/32, 46.9%
Jadad: 1-0-0-0-0 
IVS: 0.5-0-0-0-0-0.5
OPVS: 0-3-2-0-1-1-0-1
C
Treatment: 30/45, 66.7%
Control: 16/30, 53.3%
Jadad: 1-0-0-0-1 
IVS: 0.5-0-1-0-0-1
OPVS: 0-3-2-0-1-1-0-1
B
Treatment: 40/43, 93%
Control: 15/20, 75%
Jadad: 1-0-0-0-1 
IVS: 0.5-0-0.5-0-0-1
OPVS: 0-3-2-0-1-0-0-1
B
Treatment: 41/87, 47.1%
Control: 14/61, 23%
Jadad: 1-0-0-0-1 
IVS: 0.5-0-0.5-0-0-1
OPVS: 0-3-2-0-1-1-0-1
B
Treatment: 37/60, 61.7%
Control: 19/60, 31.7%
Jadad: 1-0-0-0-1
IVS: 0.5-0-0.5-0-0-1
OPVS: 0-3-2-0-1-0-0-1
C
Treatment: 41/54, 75.9%
Control: 32/52, 61.5%
Jadad: 1-0-0-0-1 
IVS: 0.5-0-0.5-0--0-1
OPVS: 0-3-2-0-1-1-0-1
B
Treatment: 35/46, 76.1%
Control: 12/26, 46.2%
Jadad: 1-0-0-0-0
IVS: 0.5-0-0.5-0-0-0.5
OPVS: 0-3-2-0-1-1-0-1
B
continued on next page
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METHODOLOgICAL ASSESSMENT
DESCRIPTION Of THE STUDIES 
Table 1 summarises the characteristics of the 17 studies. Sixteen 
trials adopted the IHS criteria for the diagnosis of migraine, 
and one trial used the Ad Hoc Committee’s criteria.21 A total 
of 2097 participants (median 91; range 62–414) were included 
in our review.
All studies compared acupuncture with western medication 
treatments. Ten studies used acupuncture alone. Six studies 
used a combined therapy of acupuncture with acupoint 
injection,22 with intravenous injection of a purified Chinese 
herb,23 with Chinese Tuina,24,25 or with hyperbaric oxygen.26,27 
The remaining study compared acupuncture plus western 
medication with western medication alone.23,28 None of the 
studies compared acupuncture with no-treatment control or 
sham/placebo acupuncture. 
QUALITy ASSESSMENT 
The median Jadad score was 2 (range 1–2) out of a possible 
score of 5; the median IVS was 2.0 (range 1.5–2.5) out of 6; 
and the median OPVS was 8 (range 7–9) out of 16. None of 
the 17 studies had more than 60% of a maximum score of 
Jadad, IVS or OPVS. 
All 17 trials were described as randomised studies. Six studies 
in which the method of randomisation was briefly mentioned 
used the order of admission or date of birth to allocate 
participants, and can be considered as quasi-randomised studies. 
Consequently, ‘C Inadequate’ was coded for these six studies. 
The remaining twelve studies were in Category B because it is 
unclear if and how the allocation concealment was conducted. 
Detailed information about allocation concealment was absent 
in eleven studies, one trial only merely stated that the sortition 
method was used.9
furthermore, no study reported details regarding the process of 
blinding. The participants were not blinded to the treatment 
allocation because western medications were the control 
intervention. The blinding of assessors was not reported in 
any of the studies. All studies gained one point for reporting 
drop-outs. In two studies, a drop-out rate of less than 10% 
was reported.21,25 The remaining studies did not have any 
drop-outs. 
Only two trials28,29 presented means and standard deviations 
of the outcome measures and were awarded one point for data 
presentation in OPVS. 
TABLE 1   Characteristics of included studies (continued)
Author and date Intervention Sample population* Outcomes# Follow-up Drop-out
Shao Y, et al. 
(2005)
Electronic acupuncture 
plus massage vs western 
medication
Acu: n = 35
WM: n = 33
▲ 6 months No
Wang LQ, et al. 
(2004)
Acupuncture plus 
hyperbaric oxygen vs 
western medication
Acu: n = 63
WM: n = 28
● 1 year No
Liu XL, et al. 
(2002) 
Acupuncture plus 
hyperbaric oxygen vs 
western medication
Acu: n = 256
WM: n = 158
■ N/A No
Zhang YK 
(2005)
Acupuncture plus 
medication vs western 
medication
Acu: n = 60
WM: n = 60
Headache 
index
No No
* Acu: acupuncture, WM: western medications
# ▲ refers to four categories of self-defined ‘global response’, named ‘cured’, ‘marked improvement’, ‘improvement’ and ‘no effect’. According to 
the definition, the participants in the ‘cured’ and ‘significantly improved’ categories had more than 50% improvement when compared with the 
baseline and were considered as respondents in this review. ■ refers to three categories of self-defined ‘global response’, named ‘cured’, ‘effective’ 
and ‘ineffective’. According to the definition, the participants in the ‘cured’ category had more than 50% improvement, and were considered as 
respondents in this review. ● refers to four categories of self-defined ‘global response’, named ‘cured’, ‘marked improvement’, ‘improvement’ 
and ‘no effect’. According to the definition, the participants in the ‘cured’, ‘significantly improved’ and ‘improved’ categories had more than 50% 
improvement, and were considered as respondents in this review. 
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In contrast to the poor reporting quality of study designs, 
most of the studies achieved satisfactory results in STRICTA, 
reporting quality of intervention, which is not assessed by any 
other measurements. All 17 trials gave detailed information for 
acupuncture rationale, needling techniques, treatment regimes, 
co-interventions and control interventions; however, none of 
the studies gave details of practitioner backgrounds (Table 2). 
ACUPUNCTURE INTERVENTION 
Twelve trials used formula acupoints. One trial employed 
formula acupoints plus Ashi points.21 The remaining four used 
semi-structured acupuncture treatment, including formula 
plus complementary acupoints based on traditional Chinese 
medicine (TCM) syndrome differentiation.9,25,26,30 The 
principles of acupuncture point selection were clearly stated in 
16 studies, including dispelling wind,22,23,25 dredging meridian 
and activating Qi and blood,27,28,31-33 and regulating the 
liver.9,10,21,24,26,29,34,35 Deqi (a feeling of numbness, heaviness, 
distension or radiation) was reported in all 17 studies.
The median treatment period was 30 days (range 5–56 days) 
with an average of 30 treatment sessions (range 5–40). In 
13 studies, participants were treated with acupuncture daily. 
Three studies gave five or six treatment sessions weekly21,30,35 
and in the remaining study, treatment was given once every 
three days.31 
The top five acupoints used in the 17 trials were gB 8 Shuaigu, 
gB 20 Fengchi, LI 4 Hegu, LR 3 Taichong, and Ex-HN 5 
Taiyang. 
CONTROL INTERVENTION 
All 17 trials used western medications as the control 
intervention. Participants took prophylactics daily. These 
drugs were categorised as Ca++ channel blocker (Nimodipine), 
antihistamines (flunarizine), anticonvulsants (Carbamazepine) 
and analgesics (Rotudin, a combination of analgesics and 
unnamed herbs). In two studies, participants were instructed to 
use NSAID (Indomethacin and Brufen) daily,25,28 which is not 
a standard western pharmacotherapy for prophylactic treatment 
of migraine. They were excluded from the meta-analysis. 
In six trials, Ergotamine, Cafergot or Ibuprofen was used for 
acute attacks in the control group only.10,21,22,24-26,31 
OUTCOME MEASURES 
All studies reported the use of at least one of the clinical-related 
outcome measures, such as frequency, intensity, and duration 
of migraine. However, apart from two studies which presented 
the means and standard deviations of clinical data,28,29 the 
remaining fifteen reported the number of participants in the 
‘cured’, ‘marked improvement’, ‘improvement’ and ‘no effect’ 
categories. None of the studies mentioned the use of a diary to 
record patients’ migraine. 
Number and percentage of 
respondents: Treatment vs Control
Quality
Allocation 
concealment†
Short-term: Treatment: 26/35,74.3%
  Control: 25/33, 75.8%
After 6 months: Treatment: 26/35, 74.3%
 Control: 17/33, 51.5%
Jadad: 1-0-0-0-1
IVS: 0.5-0-0.5-0-0-1
OPVS: 0-3-2-0-1-1-0-1
C
Treatment: 53/63, 84.1%
Control: 33/56, 58.9%
Jadad: 1-0-0-0-1 
IVS: 0.5-0-0.5-0-0-1
OPVS: 0-3-2-0-1-1-0-1
B
Treatment: 103/256, 40.2%
Control: 50/158, 31.6%
Jadad: 1-0-0-0-1 
IVS: 0.5-0-1-0--0-1
OPVS: 0-3-2-0-1-1-0-1
C
Treatment: 9.1 ± 2.07
Control: 11.7 ± 3.04
Jadad: 1-0-0-0-1
IVS: 0.5-0-0.5-0-0-1
OPVS: 0-3-2-0-1-1-0-1
B
† A: indicates adequate concealment of the allocation (e.g. by telephone randomisation, or use of consecutively 
numbered, sealed, opaque envelopes). B: indicates uncertainty about whether the allocation was adequately 
concealed (e.g. where the method of concealment is not known). C: indicates that the allocation was definitely not 
adequately concealed (e.g. open random number lists or quasi-randomisation, such as alternate days, odd/even date 
of birth, or hospital number). D: indicates the score was not assigned, i.e. allocation concealment was not used. 
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fOLLOW-UP
follow-up was not clearly mentioned in three studies, and 
one trial did not include a follow-up period. fourteen studies 
had a follow-up period ranging from one month to one year 
after treatment with a median of 4.5 months. Performance of 
the participants during the follow-up period was not reported 
separately from that immediately after acupuncture. 
Side effects of acupuncture and western medications were not 
reported. 
Results 
ACUPUNCTURE VS WESTERN 
MEDICATIONS
In total, ten studies with 1094 participants were included in 
this analysis. All 10 studies reported positive results (figure 2); 
however, the I2 statistic (61.4%) indicated significant 
heterogeneity. Thus, a random-effects model was applied in the 
data analyses. The results significantly favoured acupuncture as 
an intervention (RR 1.55; 95% CI 1.27 to 1.88). Only one 
study29 presented the details of frequency and duration of 
migraine in mean and SD (frequency per month: 0.3 ± 1.4 
vs 2.6 ± 1.6; duration in hours: 2.54 ± 1.37 vs 14.7 ±1.56). 
This study also provided the number of participants in the 
sub-groups of ‘cured’, ‘marked improvement’, ‘improvement’ 
and ‘no effect’. The number of respondents in the study was 
chosen for the meta-analysis.
ACUPUNCTURE PLUS WESTERN 
MEDICATION VS WESTERN 
MEDICATION 
There was only one study in the comparison. Zhang (2005) 
compared acupuncture plus western medication with the same 
western medication alone (Brufen). In total, 120 participants 
were randomised into two groups with 1:1 ratio. After 30 
treatment days, the acupuncture group (9.1 ± 2.07) was 
found to be statistically significantly better than the western 
medication alone group (11.7 ± 3.04) in headache index, a 
combined measure of frequency and intensity of headache. 
ACUPUNCTURE PLUS OTHER TCM 
THERAPIES VS WESTERN MEDICATIONS
four studies compared a combined therapy of acupuncture and 
other Chinese medicine (CM) therapies, including acupoint 
injection,22 intravenous injection of a purified Chinese herb23 
and Tuina24,25, respectively, with western medications. Lu25 
combined acupuncture with Chinese Tuina to compare with 
treatment with Indomethacin (NSAID) (25 mg twice a day for 
30 days), an invalid pharmacological treatment for migraine. 
In fact, frequent use of NSAIDs could lead to migraine from 
medicine overuse.36 Consequently, this study was not included 
in the meta-analysis. 
Shao24 is the only study that presented both short-term data 
and the six-month follow-up data. The results indicated that 
acupuncture with massage produced a long-term effect, although 
the short-term effect was not better than western medications. 
To be consistent with the data extracted from other studies, the 
follow-up data were included in the meta-analysis. 
The fixed-effects model was used because the I2 statistic was 
43.1%. figure 3 shows that acupuncture plus other CM 
therapies were significantly better than western medications 
control (RR 1.48, 95% CI 1.22 to 1.81). 
ACUPUNCTURE PLUS OTHER THERAPy 
VS WESTERN MEDICATION
Two studies of 503 participants combined acupuncture with 
hyperbaric oxygen to compare with western medication.26,27 
fIgURE 2 Global responses to the treatments – acupuncture versus western medications
2008  VOLUME 3  ISSUE 1Australian Journal  of Acupuncture and Chinese Medicine 11
Acupuncture for Migraine
Significant heterogeneity was indicated by the I2 statistic 
(84.7%), and a random-effects model was applied. figure 
4 indicates that the combined therapy was not statistically 
significantly better than the western medication controls (RR 
1.22, 95% CI 0.87 to 1.7). 
A COMPARISON Of OUR REVIEW WITH 
THE OTHER TWO SRS 
A comparison of findings from our review with those in the two 
previous SRs4,6 is presented in Table 3. The majority of studies 
included in the two existing SRs were published in English 
or European languages. In general, studies published in China 
had larger sample sizes, were of poorer quality, had acupuncture 
treatment more frequently and had pharmacotherapy controls 
only. All studies included in our review emphasised that the 
Deqi sensation was achieved during treatment. Only 9 out of 
26 trials reported Deqi in Melchart et al’s review,4 and 10 out 
of 25 in Scott and Deare’s review.6 
Twenty three percent of the Chinese trials (four out of 17 
studies) used semi-standardised acupuncture treatment based 
on Chinese medicine syndrome differentiation. In comparison, 
44% of the trials reported in English and European literature 
adopted this method. 
Trials published in English and European languages used 
sham/placebo acupuncture, waiting list, western medicine 
or physiotherapy as the control interventions; blinding of 
participants was common in the sham acupuncture–controlled 
trials. All of the 17 Chinese studies used western medications 
as a control. Except for two studies,25,28 all drugs used in these 
17 trials were recommended migraine medication37 and were 
similar to those of trials in the other SRs 
Discussion
This review of Chinese literature was conducted to determine 
the effect of acupuncture on migraine when compared with 
sham acupuncture, no treatment and other therapies. No 
relevant studies were identified for the first two comparisons. 
There is moderate evidence from Chinese literature supporting 
the value of acupuncture for the treatment and prevention 
of migraine when compared with western medications. 
furthermore, combining acupuncture with other modalities of 
Chinese medicine is superior to western medications. 
The major limitation of our SR is that we were not able to 
identify papers published prior to the 1980s because the 
inceptions of the two databases – Vi Pu (重庆维普) and Wan 
YY Wang, Z Zheng and CCL Xue
fIgURE 3 Global responses to the treatments – acupuncture with other traditional Chinese medicine 
   versus western medications
fIgURE 3 Global responses to the treatments – acupuncture and other therapy versus western medications
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TABLE 2   Study and control interventions of included studies
Author and date Study intervention Type of acupuncture treatment Acupuncture points and needling
Zhou JH 
(2005) 
Acupuncture alone formula acupuncture (dredging meridian 
and activating Qi and blood)
gB 8, gB 19, TE 20. Deqi mentioned.
Wang B 
(2004) 
Acupuncture alone formula acupuncture (dredging meridian 
and activating Qi and blood)
gV 15, gV 16, gV 17; dividing the distance between gV 16 and 
gB 12 into 6 equal sections, then needling the points dividing the 
sections. Deqi mentioned.
Cui R, et al. 
(2004) 
Acupuncture alone formula acupuncture (regulating the liver) gB 8, gB 20, gB 39, gB 41, LI 4, LR 3, KI 12. Deqi mentioned.
Feng SL, et al. 
(2003) 
Acupuncture alone formula acupuncture plus complementary 
point based on TCM syndrome 
differentiation
Empirical points: 1st point: 0.5 cun above gB 8; 2nd/3rd points: 
1 cun left or right of the 1st point. Complementary points: BL 23, 
KI 3 ,LR 3, or SP 9, ST 8, ST 40 or gB 20, gB 34, LR 3. Deqi 
mentioned.
Zhang YC, et al. 
(2002) 
Acupuncture alone formula acupuncture (dredging meridian 
and activating Qi and blood)
TE 21. Deqi mentioned.
Liu KY, et al. 
(2001) 
Acupuncture alone formula acupuncture (regulating the liver) Ex-HN 5, gB 8, gB 20, gB 34, gB 41, LR 3, TE 5, ST 36, start 
and end points of lower sensory area in Head acupuncture. Deqi 
mentioned. 
Li W, et al. 
(1998) 
Acupuncture alone formula acupuncture (regulating the liver) 
plus Ashi points
gV 20, gB 20, gB 39, LR 2. Complementary points: Ashi points. 
Deqi mentioned.
Chen XS 
(1997) 
Acupuncture alone formula acupuncture
(regulating the liver)
Ex-HN 5, gB 20, LR 3, ST 8, TE 5. Deqi mentioned.
Zhou LS 
(2003) 
Acupuncture alone formula acupuncture (regulating the liver) TE 5, gB 8, gB 41, gB 44, TE 3, TE 19. Deqi mentioned.
Lao JX 
(2003) 
Electrical acupuncture 
alone
formula acupuncture (regulating the liver) 
plus complementary point based on TCM 
syndrome differentiation
gB 4, TE 23. Complementary points: Ex-HN 5, gB 20, LU 7, or 
KI 3, LR 3 or LI 4, LR 2, or gB 8, ST 40. Deqi mentioned.
Wang JL, et al. 
(2004)
Acupuncture plus 
intravenous injection of a 
purified Chinese herb
formula acupuncture (dispelling wind) Ex-HN 5, gB 8, gB 20, LI 4, LR 3, TE 3. Deqi mentioned.
Liu Y, et al. 
(2002)
Acupuncture plus 
acupoint injection
formula acupuncture (dispelling wind) gV 20, Ex-HN 5, gB 8, gB 20, LI 4, LU 7, ST 8, TE 23. Deqi 
mentioned.
Lu ZQ 
(2004)
Acupuncture plus massage formula acupuncture (dispelling wind) 
plus complementary point based on TCM 
syndrome differentiation
Ex-HN 5, gV 14 gV 20, gB 20. Complementary points: 
LI 4, ST 40 or KI 3, LR 3 or LI 4, SP 6 or LU 9, ST 36. Deqi 
mentioned.
Shao Y, et al. 
(2005)
Electrical acupuncture plus 
massage
formula acupuncture (regulating the liver) Ex-HN 5, gB 4, gB 20, gB 38, gB 41, LR 3, PC 6 , TE 23. Deqi 
mentioned.
Wang LQ, et al. 
(2004)
Acupuncture plus 
hyperbaric oxygen
formula acupuncture (regulating the liver) 
plus complementary point based on TCM 
syndrome differentiation
gB 4, gB 20, TE 19, TE 23. Complementary points: BL 17, 
SP 10, or BL 12, BL 60, or SP 6, ST 40, or BL 23, KI 3. Deqi 
mentioned.
Liu XL, et al. 
(2002) 
Acupuncture plus 
hyperbaric oxygen
formula acupuncture (dredging meridian 
and activating Qi and blood)
Ex-HN 5, LI 4, LI 11, LU 4. Deqi mentioned.
Zhang YK 
(2005)
formula acupuncture plus 
medication
formula acupuncture (dredging meridian 
and activating Qi and blood)
gB 8, gB 20, LI 4, LR 3. Deqi mentioned.
Key: bid = twice per day; tid = three times per day; qd = four times per day.
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Other treatment Treatment regime
Practitioner 
background
Control intervention
No 1/day for 30 days N/A Nimodipine (Ca channel blocker) 40 mg, tid
No 1/3 days for 30 days N/A 1. Cafergot 2 tabs for acute migraine attacks; if not effective within 30 
mins, take another 1–2 tablets; max 6 tab/day.  
2. Nimodipine 30 mg bid for 30 days. 
No 6/week for 3 weeks N/A Nimodipine 40 mg, tid and oryzanol 20 mg, tid
No 5/week for 8 weeks N/A Nimodipine 40 mg, t.i.d
No 1/day for 5 days N/A flunarizine (antihistamines) 10 mg, q.d for 5 days
No 1/day for 30 days N/A Nimodipine 30 mg, tid for 30 days
No 6/week for 3 weeks N/A Carbamazepine (anticonvulsants) 100 mg, tid for 21 days
No 1/day for 20 days N/A Nimodipine 30 mg, tid for 20 days
No 1/day for 40 days N/A Ergotamine 1 mg for acute migraine attacks; if not effective, take 
another 2 mg after 30 mins; maximal dose 6 mg/day
No 1/day for 10 days, then 
rest 5 days; totally repeated 
3 times
N/A Rotudin 30 mg tid for 10 days, then rest 5 days; totally repeat 3 times
Ligustrazine Hydrochloride (川芎嗪) 100 
mL i.v. drip qd for 15 days
1 /day for 15 days N/A flunarizine 5 mg, qd
Acupoint injection using stauntoniae (野
木瓜皂甙) on Ex-HN 5 or gB 16, 2 mL 
for 8 weeks
1/day for 10 days, then 
rest 2 day, lasting 8 weeks
N/A flunarizine 5 mg, qd for 8 weeks; cafergot for acute migraine attacks.
Tuina 1/day for 30 days N/A 1. Ergotamine 1–2 mg for acute migraine attacks, if not effective, take 
another 2 mg after 30 mins; max 6 mg/day.  
2. Indomethacin (NSAID) 25 mg bid for 30 days.
Tuina along the gallbladder meridian on the 
head for 15 min
1/day for 10 days, then 
rest 3 days, totally 3 
phases.
N/A flunarizine 5 mg, qd Acute migraine attack, take ibuprofen 1–2 
tablets.
Hyperbaric oxygen 1/day for 10 days N/A 1. Cafergot (1–2 tabs for first symptoms). 
2. Nimodipine 40 mg tid and flunarizine (antihistamines) 5 mg, tid 
for 10 days.
Hyperbaric oxygen 1/day for 10 days N/A Somiton (a combination of analgesics and unnamed herbs) 500 mg, 
tid, oryzanol 10 mg, tid, and VB1 10 mg, tid for 7 days
Brufen 400 mg, t.i.d for 30 days 1/day for 30 days N/A Brufen 400 mg, tid for 30 days
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Fang (万方数据) – were 1989 and 1982 respectively. These 
two databases are the most comprehensive Chinese e-databases 
and include all the academically credible journals and theses 
published in China in the area of science and technology. 
Although studies published before the 1980s are not included 
in these databases, it is unlikely we have missed many published 
papers in this area. Apart from two of the 17 papers being 
published in 1997 and 1998, the remaining fifteen studies 
were published after 2001. 
None of the 17 studies in our review were included in the other 
two SRs,4,6 indicating that a large body of research was not 
considered when the conclusions were drawn. given that the 
Chinese studies have larger sample sizes than those conducted 
in western countries, potentially yielding a higher weighting 
in a meta-analysis, it is even more important to include such 
studies. 
A search indicated that only one journal included in our review 
(Zhongguo Zhenjiu) was indexed in PubMed (from 2005). Three 
studies16-18 in our review were published in this journal before 
2005 and so were not included in PubMed. This confirms the 
view expressed by the authors of the other two SRs that there is 
a lack of access to the Asian literature.4,6
In this review, we encountered the same difficulty that faced 
the authors of the other two SRs. Ideally, we should use the 
number of days with migraine per month or changed intensity 
or duration of migraine at the end of the treatment as the main 
outcome measure for quantitative analyses as recommended 
by the IHS.38 Only two papers presented means and standard 
deviations of these outcome measures.28,29 Due to detailed 
clinical data being unavailable, the number of respondents was 
used for meta-analyses. There are differences in the definition of 
respondents; 50% was used in our and Melchart et al’s reviews, 
and 33% in Scott and Deare’s review. Such a reduction of data 
limits our understanding of the exact effects of acupuncture on 
the frequency, intensity and duration of migraine. 
TABLE 3 A comparison of our review (overall data) and two other systematic reviews of  
   acupuncture for migraine
Our review Melchart et al. Scott and Deare
Sample size 
(median)
91 37 63
Frequency of treatment 
(sessions per week)
5–7 1–2 mostly 1–2
Deqi sensation 17/17 trials reported 9/26 trials reported 10/25 trials reported
Jadad, median 
(range)
2 (1–2) 1.5 (1–4) 2.3 (1–5)
IVS 2 (1.5–2.5) 2.5 (1–4) 3 (0.5–6)
Acupoint selection 23% of the studies chose 
acupoints according to 
Chinese medicine individual 
syndrome differentiation
N/A 44% of the studies chose 
acupoints according to 
Chinese medicine individual 
syndrome differentiation
Control intervention Western medications Physiotherapy (massage and 
relaxation), sham/placebo 
acupuncture, waiting list, 
western medications, standard 
gP care.
Physiotherapy (massage and 
relaxation), sham/placebo 
acupuncture, waiting list, 
western medications, standard 
gP care
Respondent rate 50% 50% 33%
Relative risk 
(acupuncture vs 
western medications)
1.55 (1.27–1.88)  
favours acupuncture
N/A 1.38 (1.08–1.76)  
favours acupuncture 
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Similar pharmacological treatments were used as the control 
interventions in our review and Scott and Deare’s. The effect 
size identified in our review (1.55) is comparable with the value 
reported by Scott and Deare (1.38). Considering the different 
definitions for respondents, Chinese trials have a higher success 
rate. It is unknown whether the higher success rate is due to 
publication bias reported by Vickers and colleagues,39 lower 
quality, or the differences in acupuncture treatment protocol. 
The reporting quality and internal validity are generally poor, 
as confirmed by three different scales. All 17 studies compared 
acupuncture with western medications, and participants 
could not be blinded to treatment allocation. furthermore, 
no trial described whether the acupuncturists were blinded 
to outcome assessment or whether an independent assessor/
evaluator was employed. No trials reported the detailed process 
of randomisation or the reasons for drop-out. 
Another major shortcoming of the Chinese literature is the 
assessment of the outcomes. first, the effect of acupuncture 
on acute attacks was not investigated. Second, the Chinese 
trials neither presented detailed clinical data nor separated the 
immediate effect from the long-term effect. As a result, we 
cannot determine the duration of the effect of acupuncture on 
migraine. Third, although many included studies claimed that 
they assessed the time-profile and intensity of migraine, none 
of the studies described either the use of a diary, a method 
recommended by the IHS,40 or how the data were recorded. 
The poor reporting quality and lower internal validity might 
have contributed to the over-estimation of the effect size. 
Most Chinese trials implemented nearly daily treatment, 
which is much more frequent than the treatments provided in 
studies included in the other two SRs.4,6 It is unknown whether 
frequent treatment is associated with better results. Except 
for one study using empirical points alone, the remaining 16 
trials selected traditional acupoints and provided the basis for 
point selection. All of them are in accordance with the classic 
literature. from the available data, we cannot conclude how 
frequent the treatment should be and which formula is the 
best. The ideal acupuncture treatment, in terms of frequency 
of treatment and acupoint selection, should be investigated in 
the future.
Conclusion
IMPLICATIONS fOR RESEARCH
Acupuncture shows promising effects on migraine. There is 
moderate evidence that acupuncture alone or combined with 
western medications is more effective than western medication 
for the prevention and treatment of migraine. However, the 
poor quality of the available studies and a lack of detailed 
data greatly reduced the level of overall evidence. future 
YY Wang, Z Zheng and CCL Xue
Clinical Commentary
This review indicates that acupuncture alone or 
when combined with other therapies is 1.2 to 1.5 
times more effective than western medications 
for the treatment of migraine. Formula-based 
acupuncture is used in the majority of studies. The 
most frequently used acupoints are GB 8 Shuaigu, 
GB 20 Fengchi, LI 4 Hegu, LR 3 Taichong and Ex-
HN 5 Taiyang. The findings of this review need to be 
interpreted with caution as the quality of the included 
studies is poor. 
studies should improve the reporting quality and trial design 
and present detailed data of the outcome measures. Profiles 
of the side effects of acupuncture should also be recorded. 
furthermore, it is important to include trials published in 
Chinese in meta-analyses. 
IMPLICATIONS fOR CLINICAL PRACTICE 
Acupuncture might be an effective prophylactic treatment for 
migraine. It can be used either alone or in conjunction with 
western medications. 
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